1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients - Wikidata - awgldk - TriplyDB

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients

http://www.wikidata.org/entity/Q33691958

about

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease Resolution phase lipid mediators of inflammation: agonists of resolution.Vitamin D and neurocognitive function Lipid mediators in the resolution of inflammation The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation Specialized pro-resolving mediators: endogenous regulators of infection and inflammation The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells Pro-resolving lipid mediators are leads for resolution physiology.Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study Metabolic profiling distinguishes three subtypes of Alzheimer's disease.Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.Migration of blood cells to β-amyloid plaques in Alzheimer's disease.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.Next generation therapeutics for Alzheimer's disease.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment.Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.Can inflammation be resolved in Alzheimer's disease?

P2860

Q26766462-B98A5571-29AD-4CF9-AD19-BEF2ECCFEC6F Q27687489-F5BA0FFE-30E1-479F-8866-B9E0A0ED6F2A Q28238127-B6CE9052-7697-40FF-BF6D-48A759C765F3 Q28250668-DBC1E5EC-F3DA-42B7-AB68-78B1EB2B05B9 Q28260186-AE1D9D70-218F-471E-BC76-FE2D54675AEB Q28269550-FE04703C-7C88-4437-AE6D-2A5A63456341 Q28271331-A0E1C9D4-1D9D-48A9-8515-72597610F774 Q28397861-BDAADE04-B683-463B-A999-BE4DB8B45B92 Q30829097-5CAE1AFE-756D-4E29-A50C-083AAA23C3F7 Q35120950-3B6715D9-F2CB-4409-88D5-32FE81897821 Q36100673-66DD518B-A3A0-491A-A22D-641E09115CFB Q36316280-61033EAF-014E-4F58-8AB8-8500C55A3A1A Q36407218-8B22CBC8-9830-4636-B83A-83A4F282A638 Q36639258-74C45B76-70E2-4B3E-BC4E-2E7B7B7EBFB8 Q36777563-6A094125-EFC0-49DC-AF67-2EABFFF36F6E Q37144777-26369E38-B3C3-48BC-9E90-C78C992B2317 Q37384973-1D5E8B84-10F5-4961-90B8-9A4568A99DB1 Q37510384-A3FF8181-3861-4528-8D50-ED348EA0E88D Q38370756-93BC0E2D-B56A-45F7-B485-145019A5C18D Q39249384-9EC9C102-443E-497B-8924-AD28AEEECE5C Q39320214-8FAE96D4-7775-4D07-87C2-A0DABA90AA99 Q40094392-D8A5F6C6-22F8-4A87-84A8-0AC9E585F963 Q42648058-B1B11D55-9EEF-42AD-8EF1-168112B1E06B Q42655692-BB7E486C-61A8-4662-A796-FBAB3F2006E2 Q46579757-FE1847D7-42EE-4450-B28C-B11D45FCB159 Q47441303-F3AED6CC-7BAF-4831-B1D3-19689960A3E3 Q47992037-4C729844-3F0D-46C2-BBE8-1BFAA0A888D0 Q49679435-15411412-FFDA-4563-AB07-8D4C718DA20E Q52584637-CDDCB3B8-BB9B-4654-8896-6704468BE682 Q58793290-972D256F-8B7E-4FDB-9614-164566519A67

P2860

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients

http://www.wikidata.org/entity/Q33691958

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@ast

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@en

type

label

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@ast

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@en

prefLabel

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@ast

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@en

P1433

Q33691958-676A9F26-638B-47A2-81AF-5A2822AE3CE0

P1476

Q33691958-04E9CE4C-B55F-4FD3-BBE0-B3952EFD1B4F

P2093

Q33691958-0212C2FF-F118-46B9-B4CE-27DC5058BBEA

Q33691958-0551726C-3A15-4C43-A7C2-2A9E80E4419B

Q33691958-0EBCD804-00FB-4C63-AA47-C0FADF613BB4

Q33691958-1539BDFF-BBCD-438F-BFD8-4FC9BF354655

Q33691958-69D6C525-543F-4773-864F-13065C641076

Q33691958-6A062C01-9FFB-48A6-AAFC-A030861344F7

Q33691958-C8869856-5BD7-4F7B-9924-F4925B886AE4

Q33691958-D5316832-CF0A-40D1-B42E-709A2647B556

Q33691958-D6368F9B-B90A-42A0-9744-9285C1C8F2B6

Q33691958-F0821A84-C38F-4CD7-8308-90615DBD2189

P2860

Q33691958-02EC1D55-4BDF-4B22-AD99-345DF22E07BC

Q33691958-03D721A5-D839-410C-9345-5B6E79315DB1

Q33691958-0663D129-669F-4924-871C-03EB68FA616D

Q33691958-06DA0CA0-7CF4-48F5-9BDA-EFFDAD8E7362

Q33691958-073AF00D-E112-4EC6-929D-656AB54C709D

Q33691958-0CB0027A-BA45-4615-993E-596C7B9272DD

Q33691958-0F43C087-6C75-4B72-9943-56D9E44E3392

Q33691958-1DD9D437-FAFE-4166-8951-6BC4C5C2926D

Q33691958-21C95894-2F85-46FD-AC9D-F22112E53F7A

Q33691958-31D7CCCF-ED04-40AA-97EB-18D64CF3594C

P304

Q33691958-41AFA7E0-9577-48B5-9BDF-2AED9EE17F0F

P31

Q33691958-8A86E8F6-52D0-4D51-AAAA-5DF861A7A936

P356

Q33691958-5E8E5899-E2E9-4BD2-84F2-8091321D2BD8

P433

Q33691958-EE19516D-6431-46F0-AA82-0C74805647A6

P478

Q33691958-B193F456-B52C-4452-9E5D-0B3DE0B17020

P50

Q33691958-2F10F50B-5AA6-464B-BB72-2EF5DA7F56DB

P577

Q33691958-16F74BDF-76B2-42DA-B3F6-49A914DC6951

P698

Q33691958-26096601-F74A-4F8B-B4BE-82132D12DFFA

P921

Q33691958-2C7C3F9A-6090-47F3-AD08-A32E8C42B808

Q33691958-837C1B00-F740-4E2D-AE26-4A230D356218

Q33691958-FE017BEF-5DC3-4433-8981-42EDBDF38B71

P932

Q33691958-89739E89-6886-44C1-956E-3B946209FE8F

P356

P1433

Journal of Alzheimer's Disease

P1476

1α,25-dihydroxyvitamin D3 and ...... n Alzheimer's disease patients

@en

P2093

Avi Siani

http://www.w3.org/2001/XMLSchema#string

David B Teplow

http://www.w3.org/2001/XMLSchema#string

Guanghao Liu

http://www.w3.org/2001/XMLSchema#string

Ilka Nemere

http://www.w3.org/2001/XMLSchema#string

James Sayre

http://www.w3.org/2001/XMLSchema#string

John Ringman

http://www.w3.org/2001/XMLSchema#string

Larry Magpantay

http://www.w3.org/2001/XMLSchema#string

Mark J Rosenthal

http://www.w3.org/2001/XMLSchema#string

Mathew T Mizwicki

http://www.w3.org/2001/XMLSchema#string

Michelle Mahanian

http://www.w3.org/2001/XMLSchema#string

P2860

Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models

The nuclear receptor ROR(alpha) exerts a bi-directional regulation of IL-6 in resting and reactive astrocytes

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Inflammation and Alzheimer's disease

Vitamin D, cognitive dysfunction and dementia in older adults

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors

P304

155-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-121735

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23186989

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4040018

http://www.w3.org/2001/XMLSchema#string